NetworkNewsBreaks – AREV Life Sciences Global Co
Post# of 16
(Total Views: 190)
Posted On: 02/17/2022 2:28:08 PM
NetworkNewsBreaks – AREV Life Sciences Global Corp. (CSE: AREV) (OTC: AREVF) Expands Corporate Efforts as It Advances Closer to Market with Milestone Products
AREV Life Sciences (CSE: AREV) (OTC: AREVF) today announced new corporate acquisitions and maturation of multiple product lines being matched with appointments and expanding corporate capacity in the company’s scientific advisory committee and IP council. The company has appointed Douglas Sorocco to its scientific advisory committee and IP council and has extended services with Strategic Health Resources LLC. These moves come as AREV’s expanding consumer products and therapeutic innovations pipeline enters mature stages of development. “These new additions to AREV’s corporate efforts assure acceleration of the enterprise’s immediate goals as we come closer to market entry with milestone products,” said Mike Withrow, CEO of AREV Life Sciences. “Our corporate leadership is fully committed to keeping pace with the capacities of both senior management and our advisory boards as we advance product development and research efforts in our human nutrition and preclinical phytomedicinal therapeutic research with a range of emerging corporate partners, in order to deliver value to the investors and create paradigm shifts in the treatment of inanition and to address other clinical disparities facing patient populations and the general consumer marketplace.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
AREV Life Sciences (CSE: AREV) (OTC: AREVF) today announced new corporate acquisitions and maturation of multiple product lines being matched with appointments and expanding corporate capacity in the company’s scientific advisory committee and IP council. The company has appointed Douglas Sorocco to its scientific advisory committee and IP council and has extended services with Strategic Health Resources LLC. These moves come as AREV’s expanding consumer products and therapeutic innovations pipeline enters mature stages of development. “These new additions to AREV’s corporate efforts assure acceleration of the enterprise’s immediate goals as we come closer to market entry with milestone products,” said Mike Withrow, CEO of AREV Life Sciences. “Our corporate leadership is fully committed to keeping pace with the capacities of both senior management and our advisory boards as we advance product development and research efforts in our human nutrition and preclinical phytomedicinal therapeutic research with a range of emerging corporate partners, in order to deliver value to the investors and create paradigm shifts in the treatment of inanition and to address other clinical disparities facing patient populations and the general consumer marketplace.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)AREV NanoTec Brands Inc. (AREVF) Stock Research Links
Scroll down for more posts ▼